Literature DB >> 3128507

Membrane-associated sialidase of rat liver and its decrease in hepatomas.

J Sagawa1, T Miyagi, S Tsuiki.   

Abstract

Using the particulate fraction of tissue homogenate, plasma membrane-associated sialidase was assayed at pH 4.5 with bovine brain mixed gangliosides as the substrate. The activity was lower in rat hepatoma induced by 3'-methyl-4-dimethylaminoazobenzene (MeDAB) and transplantable AH-109A rat hepatoma than in normal rat liver. The enzyme was almost quantitatively solubilized from liver particulate fraction by using 0.5% (w/v) sodium deoxycholate plus 0.2% (w/v) Triton X-100. When chromatographed on DEAE-cellulose, the solubilized activity emerged as a single peak. The enzyme thus obtained was maximally active at pH 4.5, and readily hydrolyzed mixed gangliosides but was less active toward 4-methylumbelliferyl-alpha-N-acetylneuraminic acid, 3'-sialyllactose and fetuin. The corresponding enzyme from MeDAB-induced hepatoma was indistinguishable from the liver enzyme in terms of ease of solubilization, pH-activity relationship, chromatographic behavior and substrate preference. It therefore appears that the plasma membrane-associated sialidase of hepatomas differs from that of liver only in the tissue level of activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128507      PMCID: PMC5907757          DOI: 10.1111/j.1349-7006.1988.tb00012.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


3′‐methyl‐4‐dimethyl‐aminoazobenzene
  18 in total

1.  Gangliosides of liver tumors induced by N-2-fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development.

Authors:  W D Merritt; C L Richardson; T W Keenan; D J Morré
Journal:  J Natl Cancer Inst       Date:  1978-06       Impact factor: 13.506

2.  Increase in serum and tissue glycosyltransferases and glycosidases in tumor-bearing rats.

Authors:  C Ip; T L Dao
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

3.  Cell surface glycolipids and glycoproteins in malignant transformation.

Authors:  G Yogeeswaran
Journal:  Adv Cancer Res       Date:  1983       Impact factor: 6.242

4.  Glycosyltransferases and glycosidases in Morris hepatomas.

Authors:  C H Bauer; P Vischer; H Grünholz; W Reutter
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

5.  Rat-liver lysosomal sialidase. Solubilization, substrate specificity and comparison with the cytosolic sialidase.

Authors:  T Miyagi; S Tsuiki
Journal:  Eur J Biochem       Date:  1984-05-15

6.  Glucosamine 6-phosphate synthase of regenerating rat liver.

Authors:  T Miyagi; S Tsuiki
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

7.  Studies on UDP-N-acetylglucosamine : alpha-mannoside beta-N-acetylglucosaminyltransferase of rat liver and hepatomas.

Authors:  T Miyagi; S Tsuiki
Journal:  Biochim Biophys Acta       Date:  1981-09-15

8.  Sialidase of rat hepatomas: qualitative and quantitative comparison with rat liver sialidase.

Authors:  T Miyagi; T Goto; S Tsuiki
Journal:  Gan       Date:  1984-12

9.  Enzyme activity in invasive tumors of human breast and colon.

Authors:  H B Bosmann; T C Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

10.  Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane.

Authors:  T Miyagi; S Tsuiki
Journal:  FEBS Lett       Date:  1986-10-06       Impact factor: 4.124

View more
  2 in total

1.  Tumor-promoting phorbol ester induces alterations of sialidase and sialyltransferase activities of JB6 cells.

Authors:  T Miyagi; J Sagawa; T Kuroki; Y Matsuya; S Tsuiki
Journal:  Jpn J Cancer Res       Date:  1990-12

2.  Neoplastic alteration of a membrane-associated sialidase of rat liver.

Authors:  T Miyagi; K Konno; J Sagawa; S Tsuiki
Journal:  Jpn J Cancer Res       Date:  1990-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.